Hanmi Pharm. Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was KRW 7,071.36 million compared to KRW 5,892.87 million a year ago.

Net income was KRW 146,231.16 million compared to KRW 82,791.74 million a year ago. Basic earnings per share from continuing operations was KRW 11,522 compared to KRW 6,517 a year ago. Basic earnings per share was KRW 11,522 compared to KRW 6,517 a year ago.